Biotechnology of anti-diabetic medicinal plants / / Saikat Gantait, Sandeep Kumar Verma, Amit Baran Sharangi, editors |
Pubbl/distr/stampa | Singapore : , : Springer, , [2021] |
Descrizione fisica | 1 online resource (482 pages) |
Disciplina | 615.7 |
Soggetto topico |
Medicinal plants - Biotechnology
Materia medica, Vegetable Diabetes - Alternative treatment Plantes medicinals Biotecnologia |
Soggetto genere / forma | Llibres electrònics |
ISBN | 981-16-3529-3 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910508462403321 |
Singapore : , : Springer, , [2021] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Complementary therapies and the management of diabetes and vascular disease [[electronic resource] ] : a matter of balance / / editor, Trish Dunning |
Pubbl/distr/stampa | Chichester ; ; New York, : J. Wiley, c2006 |
Descrizione fisica | 1 online resource (422 p.) |
Disciplina |
616.462
616.46206 |
Altri autori (Persone) | DunningTrisha |
Collana | Diabetes in practice |
Soggetto topico | Diabetes - Alternative treatment |
Soggetto genere / forma | Electronic books. |
ISBN |
1-280-73987-8
9786610739875 0-470-05743-2 0-470-05742-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Complementary Therapies and the Management of Diabetes and Vascular Disease; Contents; Preface; Foreword; List of Contributors; Acknowledgements; 1 Introduction to Diabetes; 1.1 Incidence and Prevalence of Diabetes; 1.2 Overview of Diabetes; 1.3 Management Strategies; 1.4 Management Targets and Regimens; 1.5 Short-term Complications; 1.6 Long-term Complications; 1.7 Psychological Aspects; 1.8 Diabetes Management Requires Integrated Approaches; 1.9 People with Diabetes' Needs, Capacities and Resources; 1.10 Health Professionals' Needs; 1.11 Integration - Is It Possible?
1.12 Complementary Therapies1.13 Summary; References; 2 Complementary Therapy Use; 2.1 Introduction; 2.2 Defining Complementary Therapies; 2.3 What Is Traditional Use?; 2.4 Philosophical Basis of CAM; 2.5 Frequency of CAM Use; 2.6 Profile of Likely CAM Users; 2.7 Culture, Health Beliefs and CAM; 2.8 Reported Adverse Events Associated with CAM; 2.9 Summary; References; 3 Complementary Medicine and Safety; 3.1 Introduction; 3.2 Practices; 3.3 Risks and safety; 3.4 Adverse Events; 3.5 Intrinsic and Extrinsic Factors; 3.6 Pre-market Safety Mechanisms; 3.7 Preventing Adverse Medicine Reactions 3.8 Safety of CM and Diabetes ManagementReferences; 4 Integrating Complementary and Conventional Therapies; 4.1 Introduction; 4.2 What is Integration?; 4.3 Concerns about Integration; 4.4 Benefits of Integration; 4.5 Obstacles to Integration; 4.6 How Can Integration Be Achieved?; 4.7 Current Integrative Models; 4.8 Regulatory Issues; 4.9 Responsibilities of Individual Conventional Practitioners Using Complementary Therapies; 4.10 Evidence-based Care and Clinical Practice Guidelines; 4.11 Guidelines for Patients Using Complementary Therapies; 4.12 Quality Use of Medicines 4.13 Documentation and communication4.14 Adverse event reporting; References; 5 Nutritional Therapies; 5.1 Introduction; 5.2 Nutritional Medicine (NM); 5.3 Nutritional Medicine Assessment Approaches; 5.4 The Zone Diet; 5.5 Total Wellbeing Diet; 5.6 Ketogenic or Atkins Diet; 5.7 Metabolic Typing and ABO Blood Type Diets; 5.8 ABO Blood Type Diet; 5.9 The USDA Food Guide Pyramid; 5.10 Detoxification Diets; 5.11 Nutritional Supplementation; 5.12 Vitamins; 5.13 Minerals; 5.15 Essential Fatty Acids; Gamma-Linolenic Acid and Omega 3 Fish Oils; 5.16 Other Key Nutrients; 5.17 Safe Use of Supplements References6 Essential Oils (Aromatherapy); 6.1 Introduction; 6.2 Aromatherapy Care Models; 6.3 Essential Oils; 6.4 Essential Oils and Diabetes Education and Management; 6.5 Precautions to Consider When Assessing the Suitability of Essential Oils in Patients with Renal Disease; 6.6 Essential Oil Use; 6.7 Mental Health and Psychological Care; 6.8 Essential Oil Application/Administration Methods; 6.9 Essential Oil Safety Issues; 6.10 Essential Oil - Conventional Medicine Interactions; References; 7 Counselling and Relaxation Therapies; 7.1 Introduction; 7.2 The Body and the Mind 7.3 Diabetes and the Psyche |
Record Nr. | UNINA-9910143710903321 |
Chichester ; ; New York, : J. Wiley, c2006 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Complementary therapies and the management of diabetes and vascular disease [[electronic resource] ] : a matter of balance / / editor, Trish Dunning |
Pubbl/distr/stampa | Chichester ; ; New York, : J. Wiley, c2006 |
Descrizione fisica | 1 online resource (422 p.) |
Disciplina |
616.462
616.46206 |
Altri autori (Persone) | DunningTrisha |
Collana | Diabetes in practice |
Soggetto topico | Diabetes - Alternative treatment |
ISBN |
1-280-73987-8
9786610739875 0-470-05743-2 0-470-05742-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Complementary Therapies and the Management of Diabetes and Vascular Disease; Contents; Preface; Foreword; List of Contributors; Acknowledgements; 1 Introduction to Diabetes; 1.1 Incidence and Prevalence of Diabetes; 1.2 Overview of Diabetes; 1.3 Management Strategies; 1.4 Management Targets and Regimens; 1.5 Short-term Complications; 1.6 Long-term Complications; 1.7 Psychological Aspects; 1.8 Diabetes Management Requires Integrated Approaches; 1.9 People with Diabetes' Needs, Capacities and Resources; 1.10 Health Professionals' Needs; 1.11 Integration - Is It Possible?
1.12 Complementary Therapies1.13 Summary; References; 2 Complementary Therapy Use; 2.1 Introduction; 2.2 Defining Complementary Therapies; 2.3 What Is Traditional Use?; 2.4 Philosophical Basis of CAM; 2.5 Frequency of CAM Use; 2.6 Profile of Likely CAM Users; 2.7 Culture, Health Beliefs and CAM; 2.8 Reported Adverse Events Associated with CAM; 2.9 Summary; References; 3 Complementary Medicine and Safety; 3.1 Introduction; 3.2 Practices; 3.3 Risks and safety; 3.4 Adverse Events; 3.5 Intrinsic and Extrinsic Factors; 3.6 Pre-market Safety Mechanisms; 3.7 Preventing Adverse Medicine Reactions 3.8 Safety of CM and Diabetes ManagementReferences; 4 Integrating Complementary and Conventional Therapies; 4.1 Introduction; 4.2 What is Integration?; 4.3 Concerns about Integration; 4.4 Benefits of Integration; 4.5 Obstacles to Integration; 4.6 How Can Integration Be Achieved?; 4.7 Current Integrative Models; 4.8 Regulatory Issues; 4.9 Responsibilities of Individual Conventional Practitioners Using Complementary Therapies; 4.10 Evidence-based Care and Clinical Practice Guidelines; 4.11 Guidelines for Patients Using Complementary Therapies; 4.12 Quality Use of Medicines 4.13 Documentation and communication4.14 Adverse event reporting; References; 5 Nutritional Therapies; 5.1 Introduction; 5.2 Nutritional Medicine (NM); 5.3 Nutritional Medicine Assessment Approaches; 5.4 The Zone Diet; 5.5 Total Wellbeing Diet; 5.6 Ketogenic or Atkins Diet; 5.7 Metabolic Typing and ABO Blood Type Diets; 5.8 ABO Blood Type Diet; 5.9 The USDA Food Guide Pyramid; 5.10 Detoxification Diets; 5.11 Nutritional Supplementation; 5.12 Vitamins; 5.13 Minerals; 5.15 Essential Fatty Acids; Gamma-Linolenic Acid and Omega 3 Fish Oils; 5.16 Other Key Nutrients; 5.17 Safe Use of Supplements References6 Essential Oils (Aromatherapy); 6.1 Introduction; 6.2 Aromatherapy Care Models; 6.3 Essential Oils; 6.4 Essential Oils and Diabetes Education and Management; 6.5 Precautions to Consider When Assessing the Suitability of Essential Oils in Patients with Renal Disease; 6.6 Essential Oil Use; 6.7 Mental Health and Psychological Care; 6.8 Essential Oil Application/Administration Methods; 6.9 Essential Oil Safety Issues; 6.10 Essential Oil - Conventional Medicine Interactions; References; 7 Counselling and Relaxation Therapies; 7.1 Introduction; 7.2 The Body and the Mind 7.3 Diabetes and the Psyche |
Record Nr. | UNINA-9910830285203321 |
Chichester ; ; New York, : J. Wiley, c2006 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Frontiers in clinical drug research -- diabetes and obesity . Volume 3 / / editor, Atta-ur-Rahman, FRS |
Pubbl/distr/stampa | Sharjah, United Arab Emirates : , : Bentham Books, , 2016 |
Descrizione fisica | 1 online resource (257 pages) : illustrations, tables |
Disciplina | 616.462 |
Collana | Frontiers in Clinical Drug Research -- Diabetes and Obesity |
Soggetto topico |
Diabetes
Diabetes - Alternative treatment Obesity |
ISBN | 1-68108-247-0 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910794748503321 |
Sharjah, United Arab Emirates : , : Bentham Books, , 2016 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Frontiers in clinical drug research -- diabetes and obesity . Volume 3 / / editor, Atta-ur-Rahman, FRS |
Pubbl/distr/stampa | Sharjah, United Arab Emirates : , : Bentham Books, , 2016 |
Descrizione fisica | 1 online resource (257 pages) : illustrations, tables |
Disciplina | 616.462 |
Collana | Frontiers in Clinical Drug Research -- Diabetes and Obesity |
Soggetto topico |
Diabetes
Diabetes - Alternative treatment Obesity |
ISBN | 1-68108-247-0 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910810336003321 |
Sharjah, United Arab Emirates : , : Bentham Books, , 2016 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Pathological Mechanisms in Diabetes / / Maria Grau, editor |
Pubbl/distr/stampa | Basel : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2023 |
Descrizione fisica | 1 online resource (258 pages) |
Disciplina | 616.462 |
Soggetto topico | Diabetes - Alternative treatment |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | ger |
Record Nr. | UNINA-9910729786803321 |
Basel : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2023 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Structure and health effects of natural products on diabetes mellitus / / Haixia Chen, Min Zhang, editors |
Edizione | [1st ed. 2021.] |
Pubbl/distr/stampa | Singapore : , : Springer, , [2021] |
Descrizione fisica | 1 online resource (VIII, 307 p. 85 illus., 16 illus. in color.) |
Disciplina | 616.462 |
Soggetto topico |
Diabetes - Alternative treatment
Naturopathy Pharmacology |
ISBN | 981-15-8791-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Chapter 1. Introduction of diabetes melitus and future prospects of natural products on diabetes melitus -- Chapter 2. Anoverview of hypoglycemic modern drugs -- Chapter 3. An overview of hypoglycemic biological drugs -- Chapter 4. An overview of hypoglycemic traditionaldrugs -- Chapter 5. Glycosides from natural sources in the treatment of diabetes mellitus -- Chapter 6. Isolation and Structure Elucidation of Hypoglycemic Compounds -- Chapter 7. Structural Characterization and Health Effects of Polysaccharides from Momordica charantia on Diabetes Mellitus -- Chapter 8. Effects of polysaccharides on reducing blood glucose based on gut microbiota alteration -- Chapter 9. An Overview of Polysaccharides and the influencefactors of Hypoglycemic Activity -- Chapter 10. Plant Secondary Metabolites with α-Glucosidase Inhibitory Activity. - Chapter 11. Rhinacanthin-C and Its Potential to Control Diabetes Mellitus -- Chapter 12. Regeneration of beta cells by inhibition of pro-apoptotic proteins through phytocompound in STZ induced diabetic albino wistar rats-invivo and insilico approach. - Chapter 13. Nitrogenous Compounds from Plant Origin in Management of -- Chapter 14. Plant Alkaloids with Antidiabetic Potential -- Chapter 15. The role of Alkaloids in the Management of Diabetes Mellitus -- Chapter 16. Traditional Indian Herbs for the Management of Diabetes Mellitus and their Herb-Drug Interaction Potentials: An Evidence-Based Review -- Chapter 17. Role of Micronutrients and Trace elements in Diabetes mellitus: A Review. |
Record Nr. | UNINA-9910483071603321 |
Singapore : , : Springer, , [2021] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|